Stage IV Lung Cancer Patient Gains New Lease on Life With Help From UC Docs
Over Thanksgiving 2016, Paul Glasser, 34, thought that a seasonal cold or the flu finally struck him, as he noticed he was losing his voice.
"My primary care physician thought it was just post-nasal drip that would clear up on its own, but it continued to worsen, so I saw an ear, nose and throat specialist, he says.
Acid reflux was considered, but then a trip to Keith Wilson, MD, associate professor in the Department of Otolaryngology and a UC Health ENT specialist, led to a different diagnosis.
"He saw that my left vocal cord was paralyzed, Glasser says. "They did a CT scan right before Christmas to find out why this was happening which was when they found the mass in my lung.
Glasser says the holiday season was not as joy-filled as anticipated, with an appointment for a biopsy awaiting him after the initial scan.
"It was terrible thinking it was cancer, but not knowing for sure, he says. "It was pretty devastating finding out it was cancer, too.
On the Tuesday after Christmas, a bronchoscopy and biopsy confirmed that Glasser had lung cancer. It was stage IV; it had also spread to his brain.
"I had a job lined up, and I was supposed to start the day of the biopsy, he says. "I was young and healthyI did CrossFit three days a week. When I heard that it was stage IV cancer, I thought it was the end of the line. I thought, Well, that is what is going to kill me. Do I have weeks or months?
Glasser was referred to John Morris, MD, PhD, co-leader of the UC Cancer Institute's Comprehensive Lung Cancer Program, professor in the Division of Hematology Oncology at the UC College of Medicine and UC Health medical oncologist. Under Morris care, his tumor underwent genetic analysis.
The test showed his lung cancer had a rare alteration called an "ALK translocation which affects only 3 to 4 percent of lung cancer. This is where two different chromosomes, the genetic material of the cell, break and abnormally recombine activating genes that can make a cell cancerous, However, this also provided insight to Morris on the best way to treat him.
"There is a class of targeted drugs that are extremely effective in treating this type of cancer, says Morris, who is also a member of the Cincinnati Cancer Consortium. "A change in voice or hoarseness, as experienced by Paul, can be a sign of lung cancer when it invades the structures in the center of the chest and injures the nerves that control the vocal cords. This type of lung cancer occurs more frequently in non-smokers and younger patients.
However, it comes with some complications.
"One of the side effects is that it can damage the liver, Glasser says, adding that he had to have regular blood tests to make sure he wasnt losing liver function. "Unfortunately, it was causing some damage, so I had to completely stop treatment for two to four weeks while my liver healed. Then, they put me back on a lower dose of the medication; as of April, Im back to a full dose of the drug.
Prior to this targeted therapy, Glasser had stereotactic radiation therapy to treat his brain tumors. He was then put on steroids and underwent surgery to repair his vocal cord; he also had speech therapy to regain use of his voice.
"I couldnt drive for a month at one point, which was very tough, and on top of that, I couldnt sleep at night, he says. "I did a lot of organizing and cleaning in those days to keep my mind and body occupied.
Glasser also worked with the UC Cancer Institutes Oncofertility Program prior to beginning treatment, in order to preserve his options for starting a family one day.
"Being young, I still wanted that choice available to me if I needed it, he says.
The treatment is working. Glassers lung mass, once roughly 7 by 7 centimeters, has nearly shrunk by half in three months; his brain tumors are almost gone completely.
"I have to take a pill twice a day and then have a number of follow up scans and check-ups, but I am really lucky, he says. "At this point, it looks like Im going to have a pretty normal life.
Glasser says the experience gave him a new perspective on lifeone that is bringing out his adventurous side.
"I was kind of reserved before all of this, and this has really helped me to kind of break out of my shell, he says. "I always wanted to go to New Orleans, and I recently took a trip there with my dad and my uncle. The cancer made me ask myself, What are you waiting for? It helped me realize that our time is really precious, and we should make the most of it. Once a picky eater, now everything is on my table. I take risks now to better myself. Life is too short.
Glasser, who has his masters degree in history, is hoping to become a high school teacher; right now, hes an online adjunct instructor for Notre Dame College in South Euclid, Ohio, and he also substitutes at local public and private high schools.
"My advice for someone in the fight with cancer is to stay positive, stay active and stay focused, he says, adding that he dove into his hobby of building scaled-down model vehicles and buildings when he was undergoing treatment. "I started volunteering at the local animal shelter and at Matthew 25: Ministries; I also continued to stay active through CrossFitif I can do it, anyone can.
"Im thankful for this second chance, and Im thankful I had my team at UC. Dr. Morris knows what hes doing, and he worked immediately to help me.
Glasser says battling cancer gave him a new perspective on life one that is bringing out his adventurous side, including a recent trip to New Orleans. Here is at Jackson Square in the French Quarter.
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.